Susceptibility of Transgenic Mice Carrying Human Prototype c-Ha-ras Gene in a Short-Term Carcinogenicity Study of Vinyl Carbamate and ras Gene Analyses of the Induced Tumors

Molecular Carcinogenesis

Volumn 20, Issue 3, 1997, Pages 298-307

  Mitsumori, Kunitoshi ^a   Wakana, Shigeharu ^b   Yamamoto, Satoshi ^c   Kodama, Yukio ^a   Yasuhara, Kazuo ^a   Nomura, Tatsuji ^b   Hayashi, Yuzo ^d   Maronpot, Robert R ^e  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

CB6F1 Tg Hras2 mouse; Forestomach tumor; Lung tumors; Murine Ki ras; Point mutation; Splenic hemangiosarcoma

Indexed keywords

MURINAE; MUS MUSCULUS;

CARBAMIC ACID VINYL ESTER; CARCINOGEN; DRUG DERIVATIVE; URETHAN;

ANGIOSARCOMA; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CODON; DISEASE PREDISPOSITION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; MALE; MOUSE; ONCOGENE RAS; PHYSIOLOGY; POINT MUTATION; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSGENIC MOUSE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANIMALS; BODY WEIGHT; CARCINOGENS; CODON; DISEASE SUSCEPTIBILITY; FEMALE; GENES, RAS; HEMANGIOSARCOMA; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; URETHANE;

EID: 0031279409     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199711)20:3<298::AID-MC6>3.0.CO;2-H     Document Type: Article

References (29)

1. Davies TS, Monro A. Marketed pharmaceutical reported to be tumorigenic in rodents. Journal of the American College of Toxicology 14:90-107, 1995.
2. Tennant RW, French JE, Spalding JW. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect 103:942-950, 1995.
3. Yamamoto S, Mitsumori K, Kodama Y, et al. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 17:2455-2461, 1996.
4. Storer RD, Cartwright ME, Cook WO, Soper KA, Nichols WW. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice. Carcinogenesis 16:285-293, 1995.
5. Saitoh A, Kimura M, Takahashi R, et al. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5:1195-1200, 1990.
6. Ando K, Saito A, Hino O, Takahashi R, Kimura M, Katsuki M. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res 52:978-982, 1992.
7. Doi ST, Kimura M, Katsuki M. Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn J Cancer Res 85:801-807, 1994.
8. 6-Ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate. Carcinogenesis 11:463-473, 1990.
9. 6-ethenoadenosine. Chem Res Toxicol 4:413-421, 1991.
10. Dahl GA, Miller EC, Miller JA. Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate. Cancer Res 40:1194-1203, 1980.
11. Reynolds SH, Wiest JS, Devereux TR, Anderson MW, You M. Proto-oncogene activation in spontaneously occurring and chemically-induced rodent and human lung tumors. In: Klein-Szanto A, Anderson M, Barrett JC, Slaga TJ (eds), Comparative Molecular Carcinogenesis. Wiley-Liss, Inc., New York, 1992, pp. 303-320.
12. Kawano R, Nishisaka T, Takeshima Y, Yonehara S, Inai K. Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane. Jpn J Cancer Res 86:802-810, 1995.
13. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-490, 1988.
14. Orita M, Iwahana H, Kanazawa H, Hyashi K, Sekiya K. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 86:2766-2770, 1989.
15. Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302:33-37, 1983.
16. Yamamoto S, Hayashi Y, Mitsumori K, Nomura T. Rapid carcinogenicity testing system using transgenic mice harboring human prototype c-Ha-ras gene. Lab Anim Sci, in press.
17. Dahl GA, Miller JA, Miller EC. Vinyl carbamate as a promutagen and a more carcinogenic analog of ethyl carbamate. Cancer Res 38:3793-3804, 1978.
18. Park KK, Liem A, Stewart BC, Miller JA. Vinyl carbamate epoxide, a major strong electrophilic, mutagenic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate (urethane). Carcinogenesis 14:441-450, 1993.
19. Barbacid M. ras genes. Annu Rev Biochem 56:779-827, 1987.
20. Ryan J, Barker PE, Nesbitt MN, Ruddle FH. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J Natl Cancer Inst 79:1351-1357, 1987.
21. Malkinson AM. The genetic basis of susceptibility to lung tumors in mice. Toxicology 54:241-271, 1989.
22. Massey TE, Devereux TR, Maronpot RR, Foley JF, Anderson MW. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1(C57BL/6JxBALB/cJ) mice. Carcinogenesis 16:1065-1069, 1995.
23. Ogawa K, Imaida K, Masui T, et al. Chemically induced lung and forestomach neoplasias in transgenic mice carrying mutant forms of the human c-Ha-ras transgene. Carcinogenesis 17:341-345, 1996.
24. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101: 125-156, 1995.
25. Stanley LA, Devereux TR, Foley J, et al. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis 13:2427-2433, 1922.
26. MTV-and DBA/2NCr mice. Carcinogenesis 7:215-220, 1986.
27. Stanley LA, Devereux TR, Foley J, et al. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis 13:2427-2433, 1992.
28. Dragani TA, Manenti G, Della Porta G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res 51:6299-6303, 1991.
29. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101:125-156, 1995.